Stakeholders' perceptions and experiences of the National Health Service diabetes prevention programme in England: qualitative study with service users, intervention providers and deliverers, commissioners and referrers.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
15 Apr 2020
Historique:
received: 01 03 2019
accepted: 26 03 2020
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 18 11 2020
Statut: epublish

Résumé

The National Health Service diabetes prevention programme in England, (NHS DPP) aims to identify people at high risk of type 2 diabetes (T2D) and offer them a face-to-face, group-based, behaviour change intervention for at least 9 months. The NHS DPP was rolled out in phases. We aimed to elicit stakeholders' perceptions and experiences of the factors influencing implementation of, and participation in, the programme during the development phase. Individual, semi-structured telephone interviews were conducted with 50 purposively sampled stakeholders: service users (n = 20); programme commissioners (n = 7); referrers (n = 8); and intervention deliverers (n = 15). Topic guides were structured using a pragmatic, theory-informed approach. Analysis employed the framework method. We identified factors that influenced participation: Risk communication at referral - stakeholders identified point of referral as a window of opportunity to offer brief advice, to provide an understanding of T2D risk and information about the programme; Perceived impact of the NHS DPP - service users highlighted the positive perceived impact on their behaviour change, the peer support provided by participating in the programme, the option to involve a relative, and the 'knock on' effect on others. Service users also voiced disappointment when blood test results still identified them at high risk after the programme; and Behavioural maintenance - participants highlighted the challenges linked to behavioural maintenance (e.g. discontinuation of active support). Factors influencing implementations were also identified: Case finding - stakeholders suggested that using community involvement to identify service users could increase reach and ensure that the workload was not solely on GP practices; Adaptability: intervention deliverers acknowledged the need to tailor advice to service users' preferences and needs; Accountability - the need to acknowledge who was responsible for what at different stages of the NHS DPP pathway; and Fidelity - stakeholders described procedures involved in monitoring service users' satisfaction, outcome data collection and quality assurance assessments. The NHS DPP offers an evidence-informed behavioural intervention for T2D prevention. Better risk communication specification could ensure consistency at the referral stage and improve participation in the NHS DPP intervention. Cultural adaptations and outreach strategies could ensure the NHS DPP contributes to reducing health inequalities.

Sections du résumé

BACKGROUND BACKGROUND
The National Health Service diabetes prevention programme in England, (NHS DPP) aims to identify people at high risk of type 2 diabetes (T2D) and offer them a face-to-face, group-based, behaviour change intervention for at least 9 months. The NHS DPP was rolled out in phases. We aimed to elicit stakeholders' perceptions and experiences of the factors influencing implementation of, and participation in, the programme during the development phase.
METHODS METHODS
Individual, semi-structured telephone interviews were conducted with 50 purposively sampled stakeholders: service users (n = 20); programme commissioners (n = 7); referrers (n = 8); and intervention deliverers (n = 15). Topic guides were structured using a pragmatic, theory-informed approach. Analysis employed the framework method.
RESULTS RESULTS
We identified factors that influenced participation: Risk communication at referral - stakeholders identified point of referral as a window of opportunity to offer brief advice, to provide an understanding of T2D risk and information about the programme; Perceived impact of the NHS DPP - service users highlighted the positive perceived impact on their behaviour change, the peer support provided by participating in the programme, the option to involve a relative, and the 'knock on' effect on others. Service users also voiced disappointment when blood test results still identified them at high risk after the programme; and Behavioural maintenance - participants highlighted the challenges linked to behavioural maintenance (e.g. discontinuation of active support). Factors influencing implementations were also identified: Case finding - stakeholders suggested that using community involvement to identify service users could increase reach and ensure that the workload was not solely on GP practices; Adaptability: intervention deliverers acknowledged the need to tailor advice to service users' preferences and needs; Accountability - the need to acknowledge who was responsible for what at different stages of the NHS DPP pathway; and Fidelity - stakeholders described procedures involved in monitoring service users' satisfaction, outcome data collection and quality assurance assessments.
CONCLUSIONS CONCLUSIONS
The NHS DPP offers an evidence-informed behavioural intervention for T2D prevention. Better risk communication specification could ensure consistency at the referral stage and improve participation in the NHS DPP intervention. Cultural adaptations and outreach strategies could ensure the NHS DPP contributes to reducing health inequalities.

Identifiants

pubmed: 32293424
doi: 10.1186/s12913-020-05160-2
pii: 10.1186/s12913-020-05160-2
pmc: PMC7158071
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

307

Subventions

Organisme : Medical Research Council
ID : MC_UU_00006/7
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K023187/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K02325X/1
Pays : United Kingdom
Organisme : School for Public Health Research
ID : IS-SPH-0211-10016

Références

BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Health Psychol Rev. 2016 Sep;10(3):277-96
pubmed: 26854092
Lancet. 2009 Nov 14;374(9702):1677-86
pubmed: 19878986
PLoS One. 2013;8(2):e57143
pubmed: 23451166
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
Qual Saf Health Care. 2005 Feb;14(1):26-33
pubmed: 15692000
BMC Public Health. 2011 Feb 18;11:119
pubmed: 21333011
Health Psychol. 2005 Nov;24(6):608-16
pubmed: 16287407
Diabetes Care. 2009 Aug;32(8):1418-20
pubmed: 19401442
Diabet Med. 2018 Apr;35(4):513-518
pubmed: 29266374
BMJ Open. 2018 Feb 21;8(2):e019467
pubmed: 29467134
Lancet. 2006 Nov 11;368(9548):1673-9
pubmed: 17098085
BMJ. 2002 May 18;324(7347):1190
pubmed: 12016185
Implement Sci. 2015 Dec 15;10:172
pubmed: 26670418
Implement Sci. 2007 Nov 30;2:40
pubmed: 18053122
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
BMJ Open Diabetes Res Care. 2015 Oct 01;3(1):e000131
pubmed: 26464804
Curr Psychiatry Rep. 2017 Sep 14;19(11):79
pubmed: 28905325
BMC Public Health. 2012 Sep 19;12:806
pubmed: 22992417
Am J Prev Med. 2008 Oct;35(4):357-63
pubmed: 18779029
BMC Public Health. 2008 Jul 10;8:235
pubmed: 18616797
Lancet. 2016 Nov 19;388(10059):2492-2500
pubmed: 27789061
BMJ. 2007 Feb 10;334(7588):299
pubmed: 17237299
Diabetes Care. 2007 Oct;30(10):2465-70
pubmed: 17586741
N Engl J Med. 2001 May 3;344(18):1343-50
pubmed: 11333990
BMC Public Health. 2009 Sep 16;9:342
pubmed: 19758428
BMJ Open. 2014 Jul 08;4(7):e004530
pubmed: 25005595
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Milbank Q. 2013 Dec;91(4):811-51
pubmed: 24320170
Eur J Public Health. 2014 Jun;24(3):508-13
pubmed: 23893129
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
Diabet Med. 2017 May;34(5):698-707
pubmed: 27589017
Health Technol Assess. 2012;16(44):1-469
pubmed: 23158845
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD004148
pubmed: 17443541
Health Psychol. 2004 Sep;23(5):443-51
pubmed: 15367063
Diabetes Res Clin Pract. 2011 Sep;93(3):443-5
pubmed: 21820195
Cochrane Database Syst Rev. 2013 May 31;(5):CD000165
pubmed: 23728631
BMJ Open. 2013 Jun 28;3(6):
pubmed: 23811173

Auteurs

Angela M Rodrigues (AM)

Department of Psychology, Northumbria University, Northumberland Building, Newcastle upon Tyne, NE1 8ST, UK. angela.rodrigues@northumbria.ac.uk.
Population Health Sciences Institute, Newcastle University, Baddiley Clark Building, Newcastle upon Tyne, NE2 4AX, UK. angela.rodrigues@northumbria.ac.uk.
Fuse: UKCRC Centre for Translational Research in Public Health, Newcastle upon Tyne, UK. angela.rodrigues@northumbria.ac.uk.

Anna Haste (A)

Fuse: UKCRC Centre for Translational Research in Public Health, Newcastle upon Tyne, UK.
Department of Psychology, School of Social Sciences, Humanities and Law, Teesside University, Middlesbrough, TS1 3BX, UK.

Linda Penn (L)

Population Health Sciences Institute, Newcastle University, Baddiley Clark Building, Newcastle upon Tyne, NE2 4AX, UK.
Fuse: UKCRC Centre for Translational Research in Public Health, Newcastle upon Tyne, UK.
Human Nutrition Research Centre, Newcastle University, Newcastle upon Tyne, UK.

Ruth Bell (R)

Population Health Sciences Institute, Newcastle University, Baddiley Clark Building, Newcastle upon Tyne, NE2 4AX, UK.

Carolyn Summerbell (C)

Fuse: UKCRC Centre for Translational Research in Public Health, Newcastle upon Tyne, UK.
Faculty of Social Sciences and Health, Durham University, Durham City, DH1 3HN, UK.

Martin White (M)

Population Health Sciences Institute, Newcastle University, Baddiley Clark Building, Newcastle upon Tyne, NE2 4AX, UK.
MRC Epidemiology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.

Ashley J Adamson (AJ)

Population Health Sciences Institute, Newcastle University, Baddiley Clark Building, Newcastle upon Tyne, NE2 4AX, UK.
Fuse: UKCRC Centre for Translational Research in Public Health, Newcastle upon Tyne, UK.
Human Nutrition Research Centre, Newcastle University, Newcastle upon Tyne, UK.

Falko F Sniehotta (FF)

Population Health Sciences Institute, Newcastle University, Baddiley Clark Building, Newcastle upon Tyne, NE2 4AX, UK.
Fuse: UKCRC Centre for Translational Research in Public Health, Newcastle upon Tyne, UK.
NIHR Policy Research Unit Behavioural Science, Baddiley Clark Building, Newcastle upon Tyne, NE2 4AX, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH